Last reviewed · How we verify

NCT06122259: MuSIFe

Febrile Illness in Guinea

Recruiting now Last updated 8 November 2023
What this trial tests

trial in Febrile Illness in 2,500 participants. Currently enrolling.

Timeline
27 March 2023
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorCentre National de Formation et de Recherche en Sante Rurale
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,500
Start date27 March 2023
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Guinea

Conditions studied

Sponsor

Centre National de Formation et de Recherche en Sante Rurale

Who can join

2 Months and older, any sex, with Febrile Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To date, the underlying causes of community-acquired fever, particularly non-malarial fever, are insufficiently documented in Guinea. Moreover, diagnostic capacity is limited, leading to inadequate prescription of antibiotics and antimalarials, as well as substantial delay in outbreak recognition. Thus, the investigators undertook a prospective observational multi-centric cohort study of febrile patients presenting at the emergency and outpatient department of selected health centers, districts and regional hospitals in four ecologically distinct sentinel health districts in Guinea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Febrile Illness

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06122259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing